Cell-free hemoglobin upregulates pulmonary endothelial heparanase expression to drive glycocalyx destruction and inflammation in sepsis

Avery M. Bogart; Anisa S. Haffizulla; Jason Lin; Nathan D. Putz; Han Noo Ri Lee; David M. Aslaner; Samantha K. Gonski; Nancy Wickersham; Kyle Riedmann; Jamie E. Meegan; Kaori Oshima; Ciara M. Shaver; Julie A. Bastarache; Eric P. Schmidt; Lorraine B. Ware

doi:10.1172/jci.insight.203911

Cell-free hemoglobin upregulates pulmonary endothelial heparanase expression to drive glycocalyx destruction and inflammation in sepsis

Avery M. Bogart,¹ Anisa S. Haffizulla,² Jason Lin,² Nathan D. Putz,² Han Noo Ri Lee,² David M. Aslaner,² Samantha K. Gonski,² Nancy Wickersham,² Kyle Riedmann,² Jamie E. Meegan,² Kaori Oshima,³ Ciara M. Shaver,¹ Julie A. Bastarache,¹ Eric P. Schmidt,³ and Lorraine B. Ware¹

Published September 22, 2026 - More info

View PDF

Abstract

Both elevated plasma cell-free hemoglobin (CFH) and heparanase-driven endothelial glycocalyx shedding are contributors to microvascular dysfunction and organ injury in sepsis. However, the mechanisms governing heparanase activation, and the potential role of CFH in this process, are not understood. Utilizing patient samples, mice with cecal slurry-induced (CS) peritonitis and elevated CFH, and human lung microvascular endothelial cells (HLMVECs), we tested the hypothesis that CFH upregulates heparanase production to drive endothelial glycocalyx degradation. In human sepsis, elevated circulating CFH was associated with higher heparanase and heparan sulfate levels, which in turn correlated with adverse clinical outcomes. CS+CFH-treated mice had increased plasma heparanase, glycocalyx degradation, and pulmonary and systemic inflammation; endothelial heparanase deletion abrogated these effects. Additionally, in both pulmonary endothelial cells isolated from CS+CFH-treated mice and HLMVECs exposed to CFH and TNF, heparanase transcription and active enzyme production were increased. The deleterious effects of CFH were attenuated by acetaminophen, a hemoprotein reductant. In summary, we demonstrate that CFH oxidation stimulates endothelial heparanase expression and activation during sepsis, leading to endothelial glycocalyx degradation, which may disrupt the endothelial barrier and result in organ injury. Our findings highlight the CFH-heparanase axis as a potential therapeutic target for endothelial glycocalyx preservation in sepsis.

Cell-free hemoglobin upregulates pulmonary endothelial heparanase expression to drive glycocalyx destruction and inflammation in sepsis

Avery M. Bogart,¹ Anisa S. Haffizulla,² Jason Lin,² Nathan D. Putz,² Han Noo Ri Lee,² David M. Aslaner,² Samantha K. Gonski,² Nancy Wickersham,² Kyle Riedmann,² Jamie E. Meegan,² Kaori Oshima,³ Ciara M. Shaver,¹ Julie A. Bastarache,¹ Eric P. Schmidt,³ and Lorraine B. Ware¹

Article tools

Metrics

Go to

Cell-free hemoglobin upregulates pulmonary endothelial heparanase expression to drive glycocalyx destruction and inflammation in sepsis

Avery M. Bogart,1 Anisa S. Haffizulla,2 Jason Lin,2 Nathan D. Putz,2 Han Noo Ri Lee,2 David M. Aslaner,2 Samantha K. Gonski,2 Nancy Wickersham,2 Kyle Riedmann,2 Jamie E. Meegan,2 Kaori Oshima,3 Ciara M. Shaver,1 Julie A. Bastarache,1 Eric P. Schmidt,3 and Lorraine B. Ware1

Article tools

Metrics

Go to

Sign up for email alerts

Avery M. Bogart,¹ Anisa S. Haffizulla,² Jason Lin,² Nathan D. Putz,² Han Noo Ri Lee,² David M. Aslaner,² Samantha K. Gonski,² Nancy Wickersham,² Kyle Riedmann,² Jamie E. Meegan,² Kaori Oshima,³ Ciara M. Shaver,¹ Julie A. Bastarache,¹ Eric P. Schmidt,³ and Lorraine B. Ware¹